Zicam Maker Investor Lawsuit Headed to Supreme Court
The drug company's challenge to a 2004 investor lawsuit will be heard this fall.
June 14, 2010 at 08:00 PM
3 minute read
The original version of this story was published on Law.com
When reports started popping up a few years back that some users of Zicam Cold Remedy claimed the drug led them to lose their sense of smell, it made big news. But some investors in Matrixx, Zicam's manufacturer, felt they learned of the alleged side effect a little too late. Now Matrixx's challenge to the investors' 2004 lawsuit will have its day in court.
The Supreme Court granted cert Monday in Matrixx Initiatives v. Siracusano. Matrixx petitioned for cert after the 9th Circuit revived the suit in 2009. Matrixx claims that if investors were to win this suit, it would have a chilling effect on the drug industry because companies would be forced to disclose even a few adverse reactions to a drug.
The investors who filed the original suit, on the other hand, claim Matrixx continued to tout the benefits of Zicam even though the company received 12 reports of bad reactions related to loss of smell between 1999 and 2003. Those positive reports allegedly led to an inflated price for Matrixx's stock.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250